Live Breaking News & Updates on Physician Perspective

Stay updated with breaking news from Physician perspective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Physicians lack consensus on patient choice between branded, generic drugs, GlobalData study finds

The U.S., Italy and Japan accounted for more than 60% of physicians who held strong opinions on whether patients should have the option to choose between branded or generic drugs. ....

Thematic Intelligence , Physician Perspective ,

Doctors lack consensus on patient choice between branded and generic drugs: GlobalData

Doctors lack consensus on patient choice between branded and generic drugs: GlobalData
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Entod Pharmaceuticals , Thematic Intelligence , Physician Perspective , Associate Project Manager ,

Healthcare workers signal greater acceptance of AI

There are variations according to different medical sectors. For example, practices such as oncology are using AI to assist their clinical works. ....

United Kingdom , Clinical Practice , Physician Perspective ,

Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative. ....

United States , Orange County Convention Center , Fosun Pharma , Prnewswire Ardelyx Inc , American Society Of Nephrology , Kyowa Kirin Co Ltd , Ardelyx Inc , American Society , Kidney Week , Kyowa Kirin , Poster Presentations , Predictive Value , Early Response , Patients Receiving Maintenance , Exhibit Hall , Serum Phosphorus , With Tenapanor , Chronic Kidney Disease , Dialysis With Severe , Reduces Interdialytic Weight Gain , Post Hoc Analysis , Kirin Poster Presentations , Japanese Hemodialysis Patients , Randomized Phase , Tenapanor Added , Phosphate Binders ,

Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022

WALTHAM, Mass., Oct. 20, 2022 /PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo. ....

United States , Orange County Convention Center , Fosun Pharma , Prnewswire Ardelyx Inc , American Society Of Nephrology , Kyowa Kirin Co Ltd , Ardelyx Inc , American Society , Kidney Week , Kyowa Kirin , Poster Presentations , Predictive Value , Early Response , Patients Receiving Maintenance Dialysis , Exhibit Hall , West Building , Serum Phosphorus , With Tenapanor , Chronic Kidney Disease , Dialysis With Severe Hyperphosphatemia , Reduces Interdialytic Weight Gain , Post Hoc Analysis , Kirin Poster Presentations , Japanese Hemodialysis Patients , Randomized Phase , Tenapanor Added ,